Advantages of the Limited Liability Corporation (LLC) Structure

LLC's aren't an unmixed blessing. Since they are relatively new, state laws permit considerable flexibility for most of the key attributes of corporate life. But balancing the freedom offered by LLC's, there is significant complexity and expense.

Question: Now that limited liability companies (LLCs) are an accepted legal structure in all states, is it a good idea for a start-up to establish itself as an LLC instead of as a traditional corporation?

Answer: Before answering, let's start with some definitions. An LLC is a creature of state law, designed to combine the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business

  • How A New Healthcare Dialogue Is Driving Market Access In Mexico

    Companies stand a better chance of securing public reimbursement in Mexico for innovative medicines if they understand changing approaches to healthcare. The shift means the emergence of managed entry agreements and a focus on economic impact, explains AMIIF, Mexico's research-based pharmaceutical industry association.

  • How Novartis Is Elevating CVD Outcomes, Driving ‘Personalized Access’ In APMA

    Novartis’s APMA chief outlines the company’s tailored approach to deliver long-term outcomes, novel access solutions via innovative financing options and shape the CVD disease ecosystem in the extraordinarily diverse region. Partnering to build AI infrastructure is another key prong.

  • India Rare Diseases: Court Shows Path For Policy Action, Funding, Price Issues-- Test-2

    A court order encompassing funding, drug pricing, clinical trials and overall policy implementation aspects is expected to bring about a paradigm shift in the treatment of rare diseases in India. Sarepta, Roche and Sanofi are among the key players that have been part of pricing discussions.